SCHEMBL723784

SCHEMBL723784

O=C(CCl)Nc1cccc(-c2cc3nccc(Oc4ccccc4)c3o2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
POLB P06746 4/20 0.53
HTT P42858 3/20 0.53
MITF O75030 2/20 0.53
MAPK1 P28482 1/20 0.53
MAPT P10636 6/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
LMNA P02545 4/20 0.46
KDM4E B2RXH2 4/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 3/20 0.46
TSHR P16473 3/20 0.46
HPGD P15428 2/20 0.46
JAK3 P52333 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RNF4 P78317 1/20 0.45
MAP2K7 O14733 5/20 0.43
HAVCR2 Q8TDQ0 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723189 0.98 ALDH1A1 (0.54) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL722298 0.94 MITF (0.56) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL723786 0.90 CYP3A4 (0.48) ALDH1A1POLBMAPK1MAPTSMN1; SMN2
SCHEMBL723476 0.90 RNF4 (0.52) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL723378 0.89 CYP3A4 (0.47) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL721887 0.85 ALDH1A1 (0.50) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL723785 0.85 BTK (0.56) JAK3BTK
SCHEMBL723570 0.85 CYP3A4 (0.46) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL723499 0.83 HTT (0.43) ALDH1A1POLBHTTMITFMAPK1
SCHEMBL721788 0.83 MITF (0.53) ALDH1A1POLBHTTMITFMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB ALDH1A1 1457/4885POLB 3460/4885HTT 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.